Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06441734

Iron Status in Autism Spectrum Disorders

to evaluate the prevalence of iron deficiency anemia in group with autism spectrum disorders in comparison to normal children group

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • children who are diagnosed with autism spectrum disorder according to DSM -V
  • not having infection inflammatory conditions chronic physical illness
  • children who are not receiving iron supplementation

Exclusion criteria

  • age below 2 years and above 12 years
  • having an infection or inflammatory conditions chronic physical illness
  • receiving iron supplementation

Treatment and study plan

cbc serum ferritin serum iron

Diagnostic Test

by using sample of blood to do cbc and serum ferritin and serum iron during 1year

Primary outcomes

  1. iron status in autism spectrum disorders

    Time frame: 1 year

    by cbc serum ferritin serum iron

Study contacts

Contact information is provided by the study sponsor or research team.

emad eldeen mahmoud hammad, professor

CONTACT

01223559943

esraa hefzy shaker

CONTACT

[email protected]

01090930692

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Iron Status in Autism Spectrum Disorders in Children Attending Assiut Pediatric University Hospital

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jun 4, 2024
Registry last updated
Jul 16, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.